Forgot password?
Sign up today and your first download is free.

The Courts

September 06, 2019 | Daily News

The prospect of Congress passing drug pricing legislation may depend in large part on the outcome of Texas v Azar, the GOP lawsuit to repeal the Affordable Care Act, according to former congressional and administration staff.

September 03, 2019 | Daily News

The federal government’s refusal to pay billions of dollars under the Affordable Care Act’s risk corridor program is a bait and switch of staggering proportions that will undermine the government’s ability to function as a trusted business partner if a lower court decision is not reversed, several issuers who participated in the health insurance exchanges and allege they are owed millions by the government tell the Supreme Court in opening briefs filed Friday (Aug. 30)

September 03, 2019 | Daily News

FDA on Friday (Aug. 30) announced a preliminary decision to reject nine more drug substances from its list of substances that can be compounded by 503B outsourcing facilities, which produce large batches of drugs using bulk drug substances for use at health care facilities.

August 29, 2019 | Daily News

Nevada Attorney General Aaron Ford has officially appealed Texas U.S. District Judge Reed O’Connor’s decision that bars HHS from enforcing the Affordable Care Act’s contraceptive coverage mandate on any person or employer with religious objections.

August 29, 2019 | Daily News

Advocates for Medicaid expansion in Nebraska filed a lawsuit Wednesday (Aug. 28) seeking to force state officials to implement voter-approved Medicaid expansion nearly a year earlier than the Republican governor’s planned October 2020 launch date.

August 28, 2019 | Daily News

OxyContin maker Purdue Pharma and its owners, the Sackler family, offered to settle thousands of lawsuits against the company for $10 billion to $12 billion, according to media reports.

August 27, 2019 | Daily News

A federal district court consolidated hospitals’ lawsuits over deep reimbursement cuts for clinic visits at off-campus facilities after the providers in both cases agreed to join their litigation. Hospitals are pushing the court to hear oral arguments in September.

August 26, 2019 | Daily News

An Oklahoma judge determined that Johnson & Johnson and its subsidiary Janssen Pharmaceuticals played a role in the opioid crisis, and he ordered the company to pay more than $572 million based on public nuisance claims.

August 23, 2019 | Daily News

A vaping product manufacturer and a newly formed trade association representing the vaping industry are asking a federal court in Mississippi to overturn FDA’s deeming rule so that the agency no longer has authority to regulate electronic nicotine delivery system (ENDS) products, including e-cigarettes.

August 21, 2019 | Daily News

HHS will appeal a court decision that struck down a Trump administration rule requiring drug makers to disclose list prices in television advertisements, the department said in a court filing on Wednesday (Aug. 21).

August 20, 2019 | Daily News

Two new lawsuits, including one brought by health care providers, are seeking to block the Trump administration’s so-called public charge rule, which aims to make it harder for legal immigrants to become permanent U.S. residents if they use Medicaid or other forms of public assistance.

August 20, 2019 | Daily News

Opioid maker Endo International’s subsidiaries, including Endo Pharmaceuticals and Par Pharmaceutical, have settled for $10 million with the plaintiffs in the ongoing multidistrict opioid litigation, the company announced Tuesday (Aug. 20).

August 16, 2019 | Daily News

Seventeen states and the District of Columbia are involved in lawsuits challenging the controversial so-called public charge rule finalized Monday, arguing that the rule undermines the role of public programs such as Medicaid and does not improve self-sufficiency for immigrants.

August 16, 2019 | Daily News

The Vapor Technology Association and Vapor Stockroom are asking a Kentucky district court to make FDA hold off on enforcing the deadline by which all electronic nicotine delivery system (ENDS) makers must submit premarket tobacco applications (PMTAs) until the agency issues rules on how to submit such applications.

August 15, 2019 | Daily News

FDA on Thursday (Aug. 15) published a proposed rule that will require color graphics depicting the negative health consequences of smoking be added to cigarette packages and in cigarette advertisements.

August 15, 2019 | Daily News

Nevada’s attorney general is still considering whether to appeal U.S. District Judge Reed O’Connor’s refusal to let the state intervene in an under-the-radar class action case, DeOtte, et al v. Azar, that bars HHS from enforcing the Affordable Care Act’s contraceptive mandate on any members of two broadly drawn classes, a spokesperson for Nevada Attorney General Aaron Ford tells Inside Health Policy.

August 14, 2019 | Daily News

A group of 22 Democratic attorneys general warned the Trump administration that it will land in court if it finalizes a proposal to revise the Affordable Care Act’s non-discrimination provision by rolling back protections for transgender individuals, eliminating language requirements for people with limited English proficiency (LEP) and reducing the number of entities that must comply.

August 12, 2019 | Daily News

The Trump administration on Monday (Aug. 12) finalized a controversial rule that will make it more difficult for legal immigrants who receive Medicaid to become permanent U.S. residents, drawing outcry from stakeholders across the health care industry who say the policy will drive up the number of uninsured patients and increase the costs of uncompensated care.

August 09, 2019 | Daily News

The White House budget office has wrapped up its review of FDA’s proposed rule to require color graphics depicting the negative health consequences of smoking be added to cigarette packages and in cigarette advertisements.

August 02, 2019 | Daily News

An industry lawyer expects FDA will exclude several more substances from its 503B bulks list now that a federal court has sided with the agency in a lawsuit challenging its process for evaluating which substances can compounded by outsourcers.